EFG Asset Management »

Rhythm Pharmaceuticals shares owned by EFG Asset Management

Quarter-by-quarter ownership of Rhythm Pharmaceuticals (RYTM) shares owned by EFG Asset Management from 13F filings

Historical chart of EFG Asset Management investment in Rhythm Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Rhythm Pharmaceuticals held by EFG Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rhythm Pharmaceuticals by EFG Asset Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $2.0M 20k 100.99

More positions owned by EFG Asset Management

NVIDIA Corporation (NVDA)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Meta Platforms Cl A (META)
Eli Lilly & Co. (LLY)
Netflix (NFLX)
Vertiv Holdings Com Cl A (VRT)
Applovin Corp Com Cl A (APP)
Marvell Technology (MRVL)
Arista Networks Com Shs (ANET)
Axon Enterprise (AXON)
Lam Research Corp Com New (LRCX)
Semtech Corporation (SMTC)
Veracyte (VCYT)

View all positions for EFG Asset Management

Top funds holding Rhythm Pharmaceuticals

Perceptive Advisors
BlackRock
RA Capital Management
Baker Bros. Advisors
Vanguard Group
PRIMECAP Management Company
NEA Management Company
FMR
State Street Corporation
Goldman Sachs Group
Federated Investors
Driehaus Capital Management
Geode Capital Management
Polar Capital Holdings
Jpmorgan Chase & Co

View all funds holding Rhythm Pharmaceuticals